{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:05:41Z","timestamp":1777039541374,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To report on the morphological characteristics and regional distribution of multifocal macular neovascularization type 3 (mMNV3).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty-two consecutive eyes of 21 patients with mMNV3 were included using multimodal imaging. The count and stage of lesions of all MNV types and the existence of exudate and hemorrhage were determined. Also, we addressed the regional distribution of MNV3 lesions between the superior-inferior and the nasal-temporal halves of the macula, and the range of the distance of the lesions from the central fovea. Furthermore, we explored the number of feeding vessels including the cilioretinal artery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found 51 lesions in 22 eyes of 21 patients. They were bifocal in 16 (73%) eyes, trifocal in 5 (23%), and quadrifocal in one (4%). No lesion of MNV1 or 2 was found. Fifteen (68%), 2 (9%), and 16 (73%) eyes were associated with retinal hard exudate, subretinal pigment epithelium exudate, and intraretinal hemorrhage, respectively. Thirty (59%) lesions were located in the temporal half of the macula, whereas 21 (41%) were located nasally (<jats:italic>p<\/jats:italic>\u2009=\u20090.07). One (2%) lesion was closer than 500\u00a0\u00b5m, 49 (96%) between 500 and 1500\u00a0\u00b5m, and one (2%) between 1500 and 3000\u00a0\u00b5m. The lesions were supplied by one arteriole in one (4%) eye, two arterioles in 16 (73%) eyes, and 3 arterioles in 5 (23%) eyes. The CRA contributed as a feeding vessel in 5 (23%) eyes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The multifocal variant of MNV3 has specific morphological and topographical characteristics. Multimodal imaging allows the understanding of the pathomorphological condition in more detail.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00417-021-05332-8","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T05:02:46Z","timestamp":1629954166000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The RAP study, report 4: morphological and topographical characteristics of multifocal macular neovascularization type 3"],"prefix":"10.1007","volume":"260","author":[{"given":"Bilal","family":"Haj Najeeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor G.","family":"Deak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Sacu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Schmidt-Erfurth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8940-8130","authenticated-orcid":false,"given":"Bianca S.","family":"Gerendas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"5332_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-2006-926977","volume":"21","author":"L Yannuzzi","year":"2001","unstructured":"Yannuzzi L, a, Negr\u00e3o S, Iida T et al (2001) Retinal angiomatous proliferation in age-related macular degeneration. Retina 21:416\u2013434. https:\/\/doi.org\/10.1055\/s-2006-926977","journal-title":"Retina"},{"key":"5332_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/IAE.0b013e3181669504","volume":"28","author":"KB Freund","year":"2008","unstructured":"Freund KB, Ho I-V, Barbazetto IA et al (2008) Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 28:201\u2013211. https:\/\/doi.org\/10.1097\/IAE.0b013e3181669504","journal-title":"Retina"},{"key":"5332_CR3","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1097\/IAE.0000000000002774","volume":"40","author":"B Haj Najeeb","year":"2020","unstructured":"Haj Najeeb B, Deak G, Schmidt-Erfurth U, Gerendas BS (2020) The RAP Study, report two. Retina 40:2255\u20132262. https:\/\/doi.org\/10.1097\/IAE.0000000000002774","journal-title":"Retina"},{"key":"5332_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8547962","volume":"2019","author":"G Aloe","year":"2019","unstructured":"Aloe G, De Sanctis CM, Strafella C et al (2019) Bilateral retinal angiomatous proliferation in a variant of retinitis pigmentosa. Case Rep Ophthalmol Med 2019:1\u20135. https:\/\/doi.org\/10.1155\/2019\/8547962","journal-title":"Case Rep Ophthalmol Med"},{"key":"5332_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/ICB.0000000000000594","volume":"13","author":"J Zerbib","year":"2019","unstructured":"Zerbib J, Blanco Garavito R, Gerber S et al (2019) Retinochoroidal anastomosis associated with enhanced s-cone syndrome. Retin Cases Brief Rep 13:295\u2013299. https:\/\/doi.org\/10.1097\/ICB.0000000000000594","journal-title":"Retin Cases Brief Rep"},{"key":"5332_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/bjophthalmol-2019-315311","volume":"105","author":"B Haj Najeeb","year":"2021","unstructured":"Haj Najeeb B, Deak GG, Schmidt-Erfurth UM, Gerendas BS (2021) RAP study, report 1: novel subtype of macular neovascularisation type III, cilioretinal MNV3. Br J Ophthalmol 105:113\u2013117. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-315311","journal-title":"Br J Ophthalmol"},{"key":"5332_CR7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/bjo.2007.115501","volume":"91","author":"SY Cohen","year":"2007","unstructured":"Cohen SY, Creuzot-Garcher C, Darmon J et al (2007) Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration. Br J Ophthalmol 91:1173\u20131176. https:\/\/doi.org\/10.1136\/bjo.2007.115501","journal-title":"Br J Ophthalmol"},{"key":"5332_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/aos.12437","volume":"92","author":"A Caramoy","year":"2014","unstructured":"Caramoy A, Ristau T, Lechanteur YT et al (2014) Environmental and genetic risk factors for retinal angiomatous proliferation. Acta Ophthalmol 92:745\u2013748. https:\/\/doi.org\/10.1111\/aos.12437","journal-title":"Acta Ophthalmol"},{"key":"5332_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/00006982-200509000-00005","volume":"25","author":"NE Gross","year":"2005","unstructured":"Gross NE, Aizman A, Brucker A et al (2005) Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina 25:713\u2013718. https:\/\/doi.org\/10.1097\/00006982-200509000-00005","journal-title":"Retina"},{"key":"5332_CR10","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1111\/aos.12748","volume":"94","author":"YS Chang","year":"2016","unstructured":"Chang YS, Kim JH, Yoo SJ et al (2016) Fellow-eye neovascularization in unilateral retinal angiomatous proliferation in a Korean population. Acta Ophthalmol 94:e49\u2013e53. https:\/\/doi.org\/10.1111\/aos.12748","journal-title":"Acta Ophthalmol"},{"key":"5332_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ajo.2012.11.001","volume":"155","author":"JH Kim","year":"2013","unstructured":"Kim JH, Kim JR, Kang SW et al (2013) Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration. Am J Ophthalmol 155:743-749.e2. https:\/\/doi.org\/10.1016\/j.ajo.2012.11.001","journal-title":"Am J Ophthalmol"},{"key":"5332_CR12","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/IAE.0000000000002489","volume":"40","author":"JH Kim","year":"2020","unstructured":"Kim JH, Chang YS, Kim JW et al (2020) Characteristics of type 3 neovascularization lesions. Retina 40:1124\u20131131. https:\/\/doi.org\/10.1097\/IAE.0000000000002489","journal-title":"Retina"},{"key":"5332_CR13","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1097\/IAE.0000000000001152","volume":"36","author":"V Ravera","year":"2016","unstructured":"Ravera V, Bottoni F, Giani A et al (2016) Retinal angiomatous proliferation diagnosis. Retina 36:2274\u20132281. https:\/\/doi.org\/10.1097\/IAE.0000000000001152","journal-title":"Retina"},{"key":"5332_CR14","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/IAE.0000000000001268","volume":"36","author":"D Su","year":"2016","unstructured":"Su D, Lin S, Phasukkijwatana N et al (2016) An updated staging system of type 3 neovascularization using spectral domain optical coherence tomography. Retina 36:S40\u2013S49. https:\/\/doi.org\/10.1097\/IAE.0000000000001268","journal-title":"Retina"},{"key":"5332_CR15","doi-asserted-by":"publisher","unstructured":"Haj Najeeb B, Deak GG, Schmidt\u2010Erfurth U, Gerendas BS (2021) The RAP study, report 3: discoloration of the macular region in patients with macular neovascularization type 3. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/aos.14866","DOI":"10.1111\/aos.14866"},{"key":"5332_CR16","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.ophtha.2015.07.008","volume":"122","author":"CE Pang","year":"2015","unstructured":"Pang CE, Messinger JD, Zanzottera EC et al (2015) The onion sign in neovascular age-related macular degeneration represents cholesterol crystals. Ophthalmology 122:2316\u20132326. https:\/\/doi.org\/10.1016\/j.ophtha.2015.07.008","journal-title":"Ophthalmology"},{"key":"5332_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/IAE.0000000000002815","volume":"41","author":"A Miere","year":"2021","unstructured":"Miere A, Sacconi R, Amoroso F et al (2021) Sub-retinal pigment epithelium multilaminar hyperreflectivity at the onset of type 3 macular neovascularization. Retina 41:135\u2013143. https:\/\/doi.org\/10.1097\/IAE.0000000000002815","journal-title":"Retina"},{"key":"5332_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/BF00166756","author":"ME Hartnett","year":"1992","unstructured":"Hartnett ME, Weiter JJ, Garsd A, Jalkh AE (1992) Classification of retinal pigment epithelial detachments associated with drusen. Graefe\u2019s Arch Clin Exp Ophthalmol. https:\/\/doi.org\/10.1007\/BF00166756","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"5332_CR19","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ophtha.2006.07.048","volume":"114","author":"BJ Wegscheider","year":"2007","unstructured":"Wegscheider BJ, Weger M, Renner W et al (2007) Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Ophthalmology 114:738\u2013742. https:\/\/doi.org\/10.1016\/j.ophtha.2006.07.048","journal-title":"Ophthalmology"},{"key":"5332_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ajo.2011.06.001","volume":"153","author":"R Dell\u2019Omo","year":"2012","unstructured":"Dell\u2019Omo R, Cassetta M, Dell\u2019Omo E et al (2012) Aqueous humor levels of vascular endothelial growth factor before and after intravitreal bevacizumab in type 3 versus type 1 and 2 neovascularization. A prospective, case-control study. Am J Ophthalmol 153:155-161.e2. https:\/\/doi.org\/10.1016\/j.ajo.2011.06.001","journal-title":"Am J Ophthalmol"},{"key":"5332_CR21","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.ajo.2014.01.018","volume":"157","author":"N Ueda-Arakawa","year":"2014","unstructured":"Ueda-Arakawa N, Ooto S, Ellabban AA et al (2014) Macular choroidal thickness and volume of eyes with reticular pseudodrusen using swept-source optical coherence tomography. Am J Ophthalmol 157:994\u20131004. https:\/\/doi.org\/10.1016\/j.ajo.2014.01.018","journal-title":"Am J Ophthalmol"},{"key":"5332_CR22","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00417-016-3375-1","volume":"254","author":"F Alten","year":"2016","unstructured":"Alten F, Heiduschka P, Clemens CR, Eter N (2016) Exploring choriocapillaris under reticular pseudodrusen using OCT-angiography. Graefe\u2019s Arch Clin Exp Ophthalmol 254:2165\u20132173. https:\/\/doi.org\/10.1007\/s00417-016-3375-1","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"5332_CR23","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s10792-017-0671-7","volume":"38","author":"I Chatziralli","year":"2018","unstructured":"Chatziralli I, Theodossiadis G, Panagiotidis D et al (2018) Choriocapillaris\u2019 alterations in the presence of reticular pseudodrusen compared to drusen: study based on OCTA findings. Int Ophthalmol 38:1887\u20131893. https:\/\/doi.org\/10.1007\/s10792-017-0671-7","journal-title":"Int Ophthalmol"},{"key":"5332_CR24","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1097\/IAE.0000000000002198","volume":"38","author":"E Borrelli","year":"2018","unstructured":"Borrelli E, Souied EH, Freund KB et al (2018) Reduced choriocapillaris flow in eyes with type 3 neovascularization and age-related macular degeneration. Retina 38:1968\u20131976. https:\/\/doi.org\/10.1097\/IAE.0000000000002198","journal-title":"Retina"},{"key":"5332_CR25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/01.iae.0000434566.57189.37","volume":"34","author":"M Sawa","year":"2014","unstructured":"Sawa M, Ueno C, Gomi F, Nishida K (2014) Incidence and characteristics of neovascularization in fellow eyes of Japanese patients with unilateral retinal angiomatous proliferation. Retina 34:761\u2013767. https:\/\/doi.org\/10.1097\/01.iae.0000434566.57189.37","journal-title":"Retina"},{"key":"5332_CR26","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1167\/iovs.17-22338","volume":"58","author":"M Paavo","year":"2017","unstructured":"Paavo M, Lee W, Merriam J et al (2017) Intraretinal correlates of reticular pseudodrusen revealed by autofluorescence and en face OCT. Investig Opthalmology Vis Sci 58:4769. https:\/\/doi.org\/10.1167\/iovs.17-22338","journal-title":"Investig Opthalmology Vis Sci"},{"key":"5332_CR27","doi-asserted-by":"publisher","first-page":"17053","DOI":"10.1038\/s41598-019-53307-x","volume":"9","author":"E Borrelli","year":"2019","unstructured":"Borrelli E, Sacconi R, Klose G et al (2019) Rotational three-dimensional OCTA: a notable new imaging tool to characterize type 3 macular neovascularization. Sci Rep 9:17053. https:\/\/doi.org\/10.1038\/s41598-019-53307-x","journal-title":"Sci Rep"},{"key":"5332_CR28","first-page":"264","volume":"30","author":"E Jackson","year":"1911","unstructured":"Jackson E (1911) Cilio-retinal and other anomalous retinal vessels. Ophthalmic Rev 30:264\u2013269","journal-title":"Ophthalmic Rev"},{"key":"5332_CR29","first-page":"598","volume":"64","author":"COLLIER M,","year":"1957","unstructured":"Collier M (1957) Incidence of cilioretinal vessels; their relation with ametropia; their association with other anomalies of the eye fundus. Bull Soc Ophtalmol Fr 64:598\u2013601","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"5332_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1055\/s-2008-1035201","volume":"208","author":"L-H Nipken","year":"1996","unstructured":"Nipken L-H, Schmidt D (1996) H\u00e4ufigkeit, Lokalisation, L\u00e4nge und Verlauf der zilioretinalen Arterie. Besteht ein Einflu\u00df auf den Verlauf der temporalen retinalen Arterien?*. Klin Monbl Augenheilkd 208:229\u2013234. https:\/\/doi.org\/10.1055\/s-2008-1035201","journal-title":"Klin Monbl Augenheilkd"},{"key":"5332_CR31","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jamaophthalmol.2018.2650","volume":"136","author":"K Snyder","year":"2018","unstructured":"Snyder K, Yazdanyar A, Mahajan A, Yiu G (2018) Association between the cilioretinal artery and choroidal neovascularization in age-related macular degeneration. JAMA Ophthalmol 136:1008\u20131014. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.2650","journal-title":"JAMA Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05332-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-021-05332-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05332-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T14:28:01Z","timestamp":1642516081000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-021-05332-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["5332"],"URL":"https:\/\/doi.org\/10.1007\/s00417-021-05332-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"assertion":[{"value":"9 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the institution\u2019s review board of each participating center for the inclusion into the multicenter core trials and from the Ethics Committee of the Medical University of Vienna for this retrospective analysis of the prospective studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"BHN: RetInSight, unrelated to this study. GD: none. SS: Roche, Novartis, and Bayer, all unrelated to this study, USE: Bayer\/Novartis\/Boehringer-Ingelheim\/Alcon\/Kinarus, RetInSight, all unrelated to this study. BG: Novartis\/Kinarus\/IDx, all unrelated to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}